RBP4 Monoclonal Antibody

This protein belongs to the lipocalin family and is the specific carrier for retinol (vitamin A alcohol) in the blood. It delivers retinol from the liver stores to the peripheral tissues. In plasma, the RBP-retinol complex interacts with transthyretin which prevents its loss by filtration through the kidney glomeruli. A deficiency of vitamin A blocks secretion of the binding protein posttranslationally and results in defective delivery and supply to the epidermal cells.

Introducing the RBP4 Monoclonal Antibody, a cutting-edge scientific tool designed to revolutionize research in the field of retinol-binding protein 4 (RBP4). This highly specific antibody is meticulously engineered to target and bind with exceptional affinity to RBP4, enabling accurate detection and analysis of this crucial protein.

Crafted with utmost precision, the RBP4 Monoclonal Antibody exhibits exceptional sensitivity and selectivity, ensuring reliable and reproducible results in various experimental settings. Its robust performance guarantees minimal background interference, facilitating precise quantification and characterization of RBP4 in biological samples.

The RBP4 Monoclonal Antibody's versatility extends to a wide range of applications, including Western blotting, immunohistochemistry, immunofluorescence, and enzyme-linked immunosorbent assays (ELISA). Its compatibility with multiple techniques allows researchers to explore diverse avenues of investigation, unraveling the intricate mechanisms underlying RBP4's role in various physiological and pathological processes.

This antibody's exceptional quality is a testament to our unwavering commitment to scientific excellence. Rigorously validated through rigorous quality control measures, the RBP4 Monoclonal Antibody guarantees consistent performance, ensuring accurate and reproducible results across experiments and laboratories.

With the RBP4 Monoclonal Antibody, researchers gain an invaluable tool to advance their understanding of RBP4's involvement in metabolic disorders, diabetes, obesity, and other related conditions. Unlock the potential of your research with this groundbreaking antibody, and pave the way for groundbreaking discoveries in the field of RBP4 biology.